In June 2011, the U.S. Food and Drug Administration (FDA) warned Americans about the potential link between Actos and bladder cancer. Around that same time, some European countries such as France and Germany pulled Actos from the market because of the concern about bladder cancer.
Generic Form of Actos Approved Despite Bladder Cancer Concerns
Since June 2011, further studies have also suggested a link between Actos and bladder cancer. Yet the drug remains on the market in the United States. Not only is Actos still available in the United States, but also the FDA approved a generic form of this diabetes drug in August 2012.
The generic form of Actos, or pioglitazone, may be prescribed to control blood sugar in adult patients with Type 2 diabetes. However, the generic version will carry the same warning as the name brand version. Specifically, patients are warned that using the drug for one year or more can result in an increased chance of developing bladder cancer.
Contact a Milwaukee Personal Injury Lawyer if You’ve Been Hurt
If you have developed bladder cancer or suffer another serious side effect for which you did not receive adequate warning from your doctor, the pharmaceutical company, or the FDA, then it is important to contact a Milwaukee class action attorney as soon as possible to discuss your legal rights and potential recovery. Our Milwaukee drug injury lawyers will fight hard for your fair and just recovery. Please call us today at 1-800-800-5678 or 414-223-4800 for a free consultation. We will be happy to explain the potential benefits of a class action lawsuit to you, and we wish you the best during your recovery.